Nom du produit:3-(4-((2-Aminoethyl)amino)-1,2,5-oxadiazol-3-yl)-4-(3-bromo-4-fluorophenyl)-1,2,4-oxadiazol-5(4H)-one
IUPAC Name:3-{4-[(2-aminoethyl)amino]-1,2,5-oxadiazol-3-yl}-4-(3-bromo-4-fluorophenyl)-4,5-dihydro-1,2,4-oxadiazol-5-one
- CAS:1204670-56-3
- Formule moléculaire:C12H10BrFN6O3
- Pureté:95%
- Numéro de catalogue:CM322142
- Poids moléculaire:385.15
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:1204670-56-3
- Formule moléculaire:C12H10BrFN6O3
- Point de fusion:-
- Code SMILES:O=C1N(C2=CC=C(F)C(Br)=C2)C(C3=NON=C3NCCN)=NO1
- Densité:
- Numéro de catalogue:CM322142
- Poids moléculaire:385.15
- Point d'ébullition:
- N° Mdl:MFCD28405061
- Stockage:
Category Infos
- Furazans
- Incorporation of heterocycles into drug molecules can enhance physical properties and biological activity. Oxadiazoles are a class of five-membered heterocycles containing one oxygen and two nitrogen atoms with special biological activity and thermodynamic properties. 1,2,4- and 1,3,4-oxadiazoles are widely used in the development of bioactive molecules, but 1,2,5-oxadiazoles (furazans) are used relatively sparingly. Compared with 1,2,4- and 1,3,4-isomers, 1,2,5-oxadiazole has unique physicochemical properties and electronic effects. The furazan ring has a strong inductive effect, comparable to that of trifluoromethyl or tetrazolyl. The unique properties of furoxan can confer specific pharmacological activities to drug-like molecules.